Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing

References

• Yip W, Hsiao WC. The Chinese health system at a crossroads. Health Aff (Millwood) 2008;27:460-8.
   PubMed Web of Science ®Google Scholar
• Wang S, Liu L, Li L, et al. Comparison of Chinese inpatients with different types of medical insurance before and after the 2009 healthcare reform. BMC Health Serv Res 2014;14:443
   PubMed Web of Science ®Google Scholar
• Liu X, Liu Y, Chen N. The Chinese experience of hospital price regulation. Health Policy Plan 2000;15:157-63
   PubMed Web of Science ®Google Scholar
• Sun Q, Santoro MA, Meng Q, et al. Pharmaceutical policy in China. Health Aff (Millwood) 2008,27:1042-50
   PubMed Web of Science ®Google Scholar
• Jiang Q, Jiang Z, Zhao M, et al. Evaluation of a pilot cooperative medical scheme in rural China: impact on gender patterns of health care utilization and prescription practices. BMC Public Health 2011;11:50
   PubMed Web of Science ®Google Scholar
• Reynolds L, Mckee M. Factors influencing antibiotic prescribing in China: an exploratory analysis. Health Policy 2009;90:32-6
   PubMed Web of Science ®Google Scholar
• Liu X, Li S. Drug policy in China. Transformations, current status and future prospects. Pharmacoeconomics 1997;12:1-9
   PubMed Web of Science ®Google Scholar
• Xiao S, Yang M, Zhou L, et al. Transition of China’s drug policy: problems in practice. Addiction 2015;110:193-4
   PubMed Web of Science ®Google Scholar
• Dong H, Bogg L, Rehnberg C, et al. Drug policy in China: pharmaceutical distribution in rural areas. Soc Sci Med 1999;48:777-86
   PubMed Web of Science ®Google Scholar
• Liu M, Huang L, Zhao D, et al. Drug access is improved by the essential drug system and “low-priced drug” policy in China. Value Health 2014;17:A789-A790
   Web of Science ®Google Scholar
• Guan X, Liang H, Xue Y, et al. An analysis of China’s national essential medicines policy. J Public Health Policy 2011;32:305-19
   PubMed Web of Science ®Google Scholar
• Li Z, Shu D, Xia M, et al. The assessment on impact of essential drugs policy on primary health care system in rural areas of Shandong Province policy and regulation division of the Health Department of Shandong Province. Technol Health Care 2015;23(Suppl 1):S169-S176
   PubMedGoogle Scholar
• Zhou Z, Su Y, Campbell B, et al. The financial impact of the ‘zero-markup policy for essential drugs’ on patients in county hospitals in western rural China. PLoS One 2015;10:e121630
   Web of Science ®Google Scholar
• Xiao Y, Zhao K, Bishai DM, et al. Essential drugs policy in three rural counties in China: what does a complexity lens add? Soc Sci Med 2013;93:220-8
   PubMed Web of Science ®Google Scholar
• Wang J, Liu X, Wang S, et al. Short-term differences in drug prices after implementation of the national essential medicines system: a case study in rural Jiangxi Province, China. Indian J Pharmacol 2015;47:535-9
   PubMed Web of Science ®Google Scholar
• Yang M, Zhou L, Hao W, et al. Drug policy in China: progress and challenges. Lancet 2014;383:509
   PubMed Web of Science ®Google Scholar
• Yi H, Miller G, Zhang L, et al. Intended and unintended consequences of China’s zero markup drug policy. Health Aff (Millwood) 2015;34:1391-8
   PubMed Web of Science ®Google Scholar
• Tian W, Yuan J, Yang D, et al. Descriptive analysis on the impacts of universal zero-markup drug policy on a Chinese urban tertiary hospital. PLoS One 2016,11:e162795
   Web of Science ®Google Scholar
• Yang C, Shen Q, Cai W, et al. Impact of the zero-markup drug policy on hospitalisation expenditure in western rural China: an interrupted time series analysis. Trop Med Int Health 2017;22:180-6
   PubMed Web of Science ®Google Scholar
• Nanjing Bureau of Statistics. Nanjing statistical yearbook 2016. Download address: www.tjcn.org
   Google Scholar
• Nanjing Health and Family Commission. Nanjing health statistical yearbook 2016. Extracted from printed copy
   Google Scholar
• Office of medical system reform, State council of China. Evaluation scheme of urban public hospitals: 2017. Extracted from printed copy
   Google Scholar
• Huang H, Li L. Impact of medical pricing reform on medical expenses and insurance expentidures: an analysis of district public hopsitals in Nanjing. Chin J Health Policy Res 2014;5:56-62 (in Chinese)
   Google Scholar
• Huang W, Chen D, Zhao G. Reinforcing the comprehensive pricing and compensation reform of urban public hospital: case of Yangzhou. Chin J Health Econ 2016;10:58-60 (in Chinese)
   Google Scholar
• Dai W, Ding J, Lv J, et al. Impact of urban public hospital pricing reform: an empirical analysis of Zhenjiang. Chin J Health Econ 2015;12:69-71 (in Chinese)
   Google Scholar
• Cao Y, Chen J. Thoughts of strategies of public hospital medical pricing reform: a survey of urban public hospitals in Jiangsu. Mod Commerc Trade Ind 2017;14:130-2 (in Chinese)
   Google Scholar
• Hu D, Xu J, Zhang Y. Impact of removing drug markups on medical insurance fund: practice from Jiangsu. Chin J Med Insur 2017;7:20-4 (in Chinese)
   Google Scholar
• Liu W, Guo R, Liu Y, et al. Impact of Beijing zero drug markup on drug use behaviors of community-based residents. Chin J Gen Prac 2010;22:2433-7 (in Chinese)
   Google Scholar
• Wang C, Zhou Y, Li J, et al. An empirical study of implementing the zero drug markups in a newly established tertiary hospital in Shanghai. Chin J Hospitals 2016;6:32-4 (in Chinese)
   Google Scholar
• Yang Y. Preliminary exploration into the abolishment of drug markup mechanism: an empirical study of pilot public hospitals in Shanghai. master's thesis Shanghai Jiaotong University; 2014 (in Chinese)
   Google Scholar
• Tan H, Yan W, Liu X, et al. Operation and development analysis of urban public hospitals in Chongqing. Chin J Health Econ 2016;5:71-4 (in Chinese)
   Google Scholar
• He Z, Ding H, Li X, et al. Effects of implementing zero drug markup policy of county public hospitals in Anhui. Chin J Health Manag 2014;8:590-2 (in Chinese)
   Google Scholar
• Liu J, Zhou D. Comparison of inhospitalization expenditures before and after comprehensive reform of urban public hospitals: case of a tertiary hospital in Anhui. Chin J Hospital Manag 2016;7:23-5 (in Chinese)
   Google Scholar
• Chen Y. Thoughts and strategic analysis of zero drug markups reform of urban public hospitals: case of a tertiary hospital pilot in Fujian. Chin J Health Ind 2015;29:24-8 (in Chinese)
   Google Scholar
• Xiong Y. Impirical study of compensation mechanism reform of urban public hospitals in China. master's thesis Southern Medical Univeristy; 2016 (in Chinese)
   Google Scholar
• Zou L, Wang D, Song X, et al. Design of compensation mechanism reform of urban public hospitals in Guangdong. Chin J Health Econ 2016;10:5-8 (in Chinese)
   Google Scholar
• Xu L, Liang Y. Innovative thoughts of exploring how to adjust the medical services prices from the costs in medical institutions: an analysis of costs of 51 hospitals in Guangdong. Contemp Hospitals 2013;6:108-10 (in Chinese)
   Google Scholar
• Zhou Z, Su Y, Zhou Z, et al. Impact of zero essential drug markup policy on inhospitalization fee: case of county public hospitals in Shaanxi. Chin J Health Policy Res 2013;12:25-32 (in Chinese)
   Google Scholar
• He Z, Xiong Y. Research on compensation mechanism of urban public hospitals. Price Theory Prac 2016;10:72-7 (in Chinese)
   Google Scholar
• Wu J, He R, Mao Y. Estimation of policy-perspective loss of removal of drug markups of urban public hospitals in Shaanxi. Chin J Health Econ 2016;4:11-13 (in Chinese)
   Google Scholar
• Su X. Effects of comprehensive public hospitals reform in Shaoxing. master's thesis Zhejiang University; 2014 (in Chinese)
   Google Scholar
• Yang L, Tan L, Li J, et al. Effects of zero drug markups in county public hospitals in Sichuan. Chin J Health Manag 2015;6:429-33 (in Chinese)
   Google Scholar
• Wu C, Dai T, Yang Y. Comparison of medical pricing and compensation reform in certain parts of China. Chin J Hospital Manag 2017;2:1-4 (in Chinese)
   Google Scholar
• Maclure M. The case-specular study design and counterfactual controls. Epidemiology 1998;9:6-7
   PubMed Web of Science ®Google Scholar
• Isett KR, Laugesen MJ, Cloud DH. Learning from New York City: a case study of public health policy practice in the Bloomberg administration. J Public Health Manag Pract 2015;21:313-22
   PubMed Web of Science ®Google Scholar
• Halloran ME, Hudgens MG. Dependent happenings: a recent methodological review. Curr Epidemiol Rep 2016;3:297-305
   PubMedGoogle Scholar
• Ewusie JE, Blondal E, Soobiah C, et al. Methods, applications, interpretations and challenges of interrupted time series (ITS) data: protocol for a scoping review. BMJ Open 2017;7:e16018
   Web of Science ®Google Scholar
• Jandoc R, Burden AM, Mamdani M, et al. Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol 2015;68:950-6
   PubMed Web of Science ®Google Scholar